Virtus ETF Advisers’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-4,509
| Closed | -$44.4K | – | 459 |
|
|
2023
Q1 | $44.4K | Sell |
4,509
-1,733
| -28% | -$17.1K | 0.02% | 432 |
|
|
2022
Q4 | $117K | Buy |
6,242
+197
| +3% | +$3.69K | 0.06% | 428 |
|
|
2022
Q3 | $125K | Buy |
6,045
+44
| +0.7% | +$910 | 0.05% | 386 |
|
|
2022
Q2 | $125K | Buy |
6,001
+3,814
| +174% | +$79.4K | 0.05% | 372 |
|
|
2022
Q1 | $94K | Sell |
2,187
-129
| -6% | -$5.55K | 0.04% | 313 |
|
|
2021
Q4 | $139K | Buy |
2,316
+328
| +16% | +$19.7K | 0.05% | 361 |
|
|
2021
Q3 | $171K | Sell |
1,988
-104
| -5% | -$8.95K | 0.08% | 307 |
|
|
2021
Q2 | $233K | Sell |
2,092
-312
| -13% | -$34.8K | 0.1% | 236 |
|
|
2021
Q1 | $268K | Buy |
2,404
+42
| +2% | +$4.68K | 0.11% | 269 |
|
|
2020
Q4 | $251K | Buy |
+2,362
| New | +$251K | 0.1% | 312 |
|
|
2019
Q2 | – | Sell |
-4,412
| Closed | -$197K | – | 440 |
|
|
2019
Q1 | $197K | Sell |
4,412
-621
| -12% | -$27.7K | 0.42% | 90 |
|
|
2018
Q4 | $242K | Sell |
5,033
-3,634
| -42% | -$175K | 0.04% | 164 |
|
|
2018
Q3 | $578K | Sell |
8,667
-6,197
| -42% | -$413K | 0.06% | 105 |
|
|
2018
Q2 | $699K | Buy |
14,864
+299
| +2% | +$14.1K | 0.62% | 102 |
|
|
2018
Q1 | $823K | Buy |
14,565
+7,827
| +116% | +$442K | 0.71% | 68 |
|
|
2017
Q4 | $334K | Buy |
6,738
+3,302
| +96% | +$164K | 0.42% | 110 |
|
|
2017
Q3 | $261K | Buy |
3,436
+314
| +10% | +$23.9K | 0.04% | 136 |
|
|
2017
Q2 | $294K | Sell |
3,122
-239
| -7% | -$22.5K | 0.04% | 128 |
|
|
2017
Q1 | $267K | Buy |
3,361
+322
| +11% | +$25.6K | 0.05% | 155 |
|
|
2016
Q4 | $253K | Buy |
3,039
+1,034
| +52% | +$86.1K | 0.08% | 138 |
|
|
2016
Q3 | $224K | Hold |
2,005
| – | – | 0.11% | 130 |
|
|
2016
Q2 | $222K | Sell |
2,005
-1,369
| -41% | -$152K | 0.16% | 123 |
|
|
2016
Q1 | $353K | Buy |
+3,374
| New | +$353K | 0.49% | 55 |
|